Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the Women’s Health Market During the Forecast Period, and Why?

The market size of women’s health has seen a consistent increase over the past years. There is expected growth from $43.53 billion in 2024 to $45.5 billion in 2025, indicating a compound annual growth rate (CAGR) of 4.5%. The surge observed in the historical period can be credited to advancements in reproductive medicine, enhanced awareness initiatives, empowerment drives, improvement in prenatal and postnatal care, and the development of hormone replacement therapies.

Experts predict substantial growth for the women’s health market in the coming years. The market is estimated to reach $58.07 billion by 2029, boasting a compound annual growth rate (CAGR) of 6.3%. This projected growth throughout the forecast period can be attributed to advances in precision gynecological medicine, an increase in clinical trials focusing on females, the wide application of non-invasive prenatal testing, broader availability of fertility treatments, and a heightened emphasis on mental health. The forecast period will predominantly feature trends such as digital health solutions, fertility tracking, reproductive health advancements, non-hormonal contraception options, maternal health and pregnancy monitoring enhancements, innovations in women’s health diagnostics, and artificial intelligence integration.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the women’s health Market?

The increase in health conditions specific to women is anticipated to spur the growth of the women’s health market. Factors such as family history, advanced age, early onset of menstruation or menopause after the age of 55, and obesity are leading to an elevated occurrence of conditions like anemia, osteoporosis, breast cancer, menopause, and others. This escalating incidence of women-related health conditions fuels the need for products and services focused on women’s health, ensuring their wellbeing. For example, the American Cancer Society, a non-profit organization focused on eradicating cancer, indicated in a January 2023 article that cervical cancer used to be one of the significant causes of death due to cancer in American women. It projected that approximately 13,960 new invasive cervical cancer cases would be diagnosed in the USA in 2023, resulting in around 4,310 deaths. Consequently, this increasing occurrence of health conditions specific to women is contributing to the expansion of the women’s health market.

Request Your Free Women’s Health Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=8017&type=smp

Which Companies Are Poised to Shape the Future of the Women’s Health Market?

Major companies operating in the women’s health market are:

• AbbVie Inc._x000D_

• Bayer AG_x000D_

• Merck & Co Inc._x000D_

• Pfizer Inc._x000D_

• Agile Therapeutics_x000D_

What Are the Latest Innovations and Trends Influencing the Women’s Health Market?

Advancements in the sphere of women’s health serve as a critical trajectory in the women’s health market. To consolidate their positioning, leading enterprises functioning within the women’s health sector are introducing novel products. For example, in July 2022, GE Healthcare, a medical technology firm based in the US, unveiled the Voluson Expert 22. This cutting-edge product added to the company’s gamut of women’s health strengthens image quality and boosts flexibility in imaging operations, courtesy its graphic-based beam-former technology. Integrated with premier tools facilitated by Artificial Intelligence (AI), it enhances uniformity during check-ups and minimizes the quantity of mandatory tasks.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/womens-health-global-market-report

Which Segments of the Women’s Health Market Hold the Most Potential for Future Development?

The women’s health market covered in this report is segmented –

1) By Product Type: Devices, Drugs, Pharmaceutical Pipeline

2) By Age: 50 Years & above , Other Ages

3) By Treatment Type: Hormonal Treatment, Non-Hormonal Treatment, Surgeries

4) By Application: Postmenopausal Osteoporosis, Hormonal Infertility, Endometriosis & Uterine Fibroids, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Devices: Diagnostic Devices, Contraceptive Devices, Fertility Monitoring Devices, Gynecological Surgical Devices, Breast Pumps

2) By Drugs: Hormonal Therapies, Fertility Drugs, Osteoporosis Drugs, Menopause Treatment Drugs, Endometriosis Drugs, Contraceptives

3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause, New Fertility Treatments, Novel Contraceptives, Drugs for Gynecological Conditions, Hormone Replacement Therapy Developments

What Regions Are Contributing Significantly to the Growth of the Women’s Health Market?

North America was the largest region in the women’s health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women’s health market report during the forecast period. The regions covered in the women’s health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Scope and Reach of the Women’s Health Market Defined?

Women’s health refers to the branch of medicine and healthcare that focuses on the diagnosis, treatment, and prevention of diseases and conditions that specifically affect women. It encompasses a wide range of issues including reproductive health, menstrual health, pregnancy and childbirth, menopause, and conditions such as breast and ovarian cancers. It also addresses other health concerns that disproportionately affect women, such as osteoporosis, cardiovascular disease, and autoimmune disorders.

Browse Through More Similar Reports By The Business Research Company:

Gynecology Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/gynecology-drugs-global-market-report

Fertility Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: